Press-release for stocks for nvs

| -1.52% | O: -1.55% H: 4.43% C: 0.03%
NVS | News | $85.28 0.53% 0.02% |

| 2.1% | O: 1.86% H: 1.05% C: 0.24%
LLY | News S | $327.27 0.51% 0.04% |

| 2.47% | O: 1.32% H: 0.0% C: 0.0%
GSK | News | $43.7 0.02% 0.05% |

| 0.02% | O: -0.16% H: 0.61% C: 0.18%
GLAXF | News | $21.1 |

| 4.22% | O: 0.47% H: 3.73% C: 3.73%
PFE | News | $51.88 0.56% 0.04% |

| 2.25% | O: 1.46% H: 1.45% C: 0.78%
SPPI | News A | $0.8667 -1.51% 0.0% |

| -2.27% | O: 0.0% H: 2.28% C: -2.27%
SNYNF | News | $104.5 |

| 4.15% | O: 4.15% H: 0.0% C: 0.0%
BMY | News | $79.98 1.29% 0.34% |

| 1.73% | O: 0.78% H: 1.72% C: 0.95%
SNY | News | $52.62 -1.5% -0.41% |

| 0.32% | O: 0.53% H: 0.0% C: 0.0%
AZN | News | $66.465 -0.65% -0.42% |

| 0.02% | O: -0.36% H: 1.22% C: 0.38%
immunotherapy report therapy cancer market

Cancer Gene Therapy Market to Grow at 10.1% through 2032, Amid High Adoption in Breast Cancer Treatment - Future Market Insights, Inc.
Published: 2022-06-27 (Crawled : 15:20) - prnewswire.com
CRNX | News A | $18.59 -5.2% 0.0% |

| -5.2% | O: 0.66% H: 1.22% C: -5.83%
AZN | News | $66.465 -0.65% -0.42% |

| 0.02% | O: -0.36% H: 1.22% C: 0.38%
ADAP | News S | $1.71 5.56% 3.09% |

| 4.94% | O: 1.85% H: 6.67% C: 3.03%
AZNCF | News | $129.21 |

| -1.52% | O: -1.55% H: 4.43% C: 0.03%
NVS | News | $85.28 0.53% 0.02% |

| 2.1% | O: 1.86% H: 1.05% C: 0.24%
GSK | News | $43.7 0.02% 0.05% |

| 0.02% | O: -0.16% H: 0.61% C: 0.18%
GLAXF | News | $21.1 |

| 4.22% | O: 0.47% H: 3.73% C: 3.73%
AMGN | News | $244.89 -0.2% -0.56% |

| -0.21% | O: -0.08% H: 0.45% C: -0.13%
treatment therapy cancer market

Valued to be $104.2 Million by 2026, Eye Health Supplements Slated for Robust Growth Worldwide
Published: 2022-06-27 (Crawled : 14:00) - prnewswire.com
PFE | News | $51.88 0.56% 0.04% |

| 2.25% | O: 1.46% H: 1.45% C: 0.78%
NVS | News | $85.28 0.53% 0.02% |

| 2.1% | O: 1.86% H: 1.05% C: 0.24%
for health eye growth

Valued to be $12.9 Billion by 2026, Crohn`s Disease (CD) Therapy Slated for Robust Growth Worldwide
Published: 2022-06-27 (Crawled : 12:20) - prnewswire.com
NVO | News | $112.89 0.69% 0.0% |

| 0.97% | O: 0.78% H: 0.97% C: 0.19%
CCXI | News | $26.01 -0.53% -4.4% |

| -6.07% | O: -4.88% H: 1.04% C: -1.25%
AZN | News | $66.465 -0.65% -0.42% |

| 0.02% | O: -0.36% H: 1.22% C: 0.38%
AZNCF | News | $129.21 |

| -1.52% | O: -1.55% H: 4.43% C: 0.03%
NVS | News | $85.28 0.53% 0.02% |

| 2.1% | O: 1.86% H: 1.05% C: 0.24%
PFE | News | $51.88 0.56% 0.04% |

| 2.25% | O: 1.46% H: 1.45% C: 0.78%
JNJ | News | $182.12 -0.09% 0.1% |

| 1.04% | O: 0.78% H: 0.94% C: 0.26%
disease for therapy growth

Irritable Bowel Syndrome Treatment Market to Surpass US$ 3,902.9 Million by 2030 - Coherent Market Insights
Published: 2022-06-24 (Crawled : 18:00) - prnewswire.com
ALPMY | News | $16.205 |

Manufacturing

| 0.19% | O: 4.33% H: 0.0% C: -2.44%
ALPMF | News | $15.83 |

| 0.48% | O: 0.99% H: 0.0% C: -0.5%
ABBV | News | $153.14 0.53% 0.04% |

| 3.19% | O: 1.57% H: 0.0% C: 0.0%
BHC A | $8.68 -0.8% 0.35% |

| 19.39% | O: 5.78% H: 13.91% C: 13.78%
IRWD | $11.59 2.57% 0.18% |

| 4.98% | O: 0.27% H: 2.08% C: 1.99%
TAK | News | $14.06 1.59% 0.0% |

| 2.4% | O: 0.36% H: 0.0% C: 0.0%
NVS | News | $85.28 0.53% 0.02% |

| 4.53% | O: 2.38% H: 0.0% C: 0.0%
treatment market

Psoriasis Treatment Market Players Observe Rising Trend of Personalized Medicines, According to TMR Report
Published: 2022-06-24 (Crawled : 12:00) - prnewswire.com
AZN | News | $66.465 -0.65% -0.42% |

| 4.43% | O: 4.41% H: 0.0% C: 0.0%
JNJ | News | $182.12 -0.09% 0.1% |

| 3.0% | O: 1.94% H: 0.0% C: 0.0%
PFE | News | $51.88 0.56% 0.04% |

| 5.28% | O: 2.96% H: 0.0% C: 0.0%
AZNCF | News | $129.21 |

| 0.43% | O: 0.64% H: 4.18% C: 1.33%
NVS | News | $85.28 0.53% 0.02% |

| 4.53% | O: 2.38% H: 0.0% C: 0.0%
LLY | News S | $327.27 0.51% 0.04% |

| 5.87% | O: 3.32% H: 0.0% C: 0.0%
treatment report psoriasis market

Novartis receives positive CHMP opinion for Scemblix®, a novel treatment for adult patients with chronic myeloid leukemia
Published: 2022-06-24 (Crawled : 12:00) - globenewswire.com
NVS | News | $85.28 0.53% 0.02% |

| 4.53% | O: 2.38% H: 0.0% C: 0.0%
scemblix treatment for chmp novartis leukemia positive

Manufacturing

| 0.19% | O: 4.33% H: 0.0% C: -2.44%
SNY | News | $52.62 -1.5% -0.41% |

| 3.83% | O: 3.49% H: 0.0% C: 0.0%
ALPMF | News | $15.83 |

| 0.48% | O: 0.99% H: 0.0% C: -0.5%
ABBV | News | $153.14 0.53% 0.04% |

| 3.19% | O: 1.57% H: 0.0% C: 0.0%
GLAXF | News | $21.1 |

| 5.59% | O: 3.19% H: 2.28% C: -1.81%
AMGN | News | $244.89 -0.2% -0.56% |

| 1.27% | O: 0.92% H: 0.82% C: 0.56%
GSK | News | $43.7 0.02% 0.05% |

| 2.75% | O: 1.79% H: 0.95% C: 0.92%
NVS | News | $85.28 0.53% 0.02% |

| 4.53% | O: 2.38% H: 0.0% C: 0.0%
GLMD | $0.4825 3.63% |

| 5.26% | O: 1.21% H: 0.0% C: -3.5%
europe growth market

Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments
Published: 2022-06-23 (Crawled : 01:00) - globenewswire.com
NVS | News | $85.28 0.53% 0.02% |

| 4.84% | O: 0.3% H: 0.0% C: 0.0%
research disease novartis

Novartis Tafinlar + Mekinist receives FDA approval for first tumor-agnostic indication for BRAF V600E solid tumors
Published: 2022-06-22 (Crawled : 00:00) - globenewswire.com
NVS | News | $85.28 0.53% 0.02% |

| 4.84% | O: 0.3% H: 0.0% C: 0.0%
fda for novartis approval tafinlar

Global Recombinant Vaccines Market to Surpass US$ 1,809.7 Million by 2030 - Coherent Market Insights
Published: 2022-06-22 (Crawled : 18:00) - prnewswire.com
NVS | News | $85.28 0.53% 0.02% |

| 3.19% | O: -1.57% H: 0.0% C: 0.0%
JNJ | News | $182.12 -0.09% 0.1% |

| 7.29% | O: 1.36% H: 0.0% C: 0.0%
SNY | News | $52.62 -1.5% -0.41% |

| 5.33% | O: -0.4% H: 0.0% C: 0.0%
market

Alladapt Announces Completion of Oversubscribed $119 Million Institutional Financing
Published: 2022-06-22 (Crawled : 12:00) - biospace.com/
NVS | News | $85.28 0.53% 0.02% |

| 3.19% | O: -1.57% H: 0.0% C: 0.0%

Novartis expands Beacon of Hope through alliances with Historically Black Medical Schools to address systemic health disparities
Published: 2022-06-22 (Crawled : 12:00) - prnewswire.com
NVS | News | $85.28 0.53% 0.02% |

| 3.19% | O: -1.57% H: 0.0% C: 0.0%
SNY | News | $52.62 -1.5% -0.41% |

| 5.33% | O: -0.4% H: 0.0% C: 0.0%
beacon novartis health

Novartis plans to petition the U.S. Court of Appeals for the Federal Circuit for further review to uphold validity of the Gilenya® (fingolimod) dosing regimen patent
Published: 2022-06-21 (Crawled : 20:00) - globenewswire.com
NVS | News | $85.28 0.53% 0.02% |

| 3.19% | O: -1.57% H: 0.0% C: 0.0%
gilenya patent for novartis review

Liver Cancer Drugs Market size to grow by USD 5.29 billion | Market Research Insights highlight the increasing incidence of liver cancer as Key Driver | Technavio
Published: 2022-06-21 (Crawled : 03:00) - prnewswire.com
AZN | News | $66.465 -0.65% -0.42% |

| 8.66% | O: 2.03% H: 0.0% C: 0.0%
NVS | News | $85.28 0.53% 0.02% |

| 4.65% | O: 1.41% H: 0.0% C: 0.0%
research liver cancer market

Global Meningitis Vaccines Market to Surpass US$ 6,669.3 Million by 2030 - Coherent Market Insights
Published: 2022-06-20 (Crawled : 19:00) - prnewswire.com
NVS | News | $85.28 0.53% 0.02% |

| 4.65% | O: 1.41% H: 0.0% C: 0.0%
SNY | News | $52.62 -1.5% -0.41% |

| 6.8% | O: 1.4% H: 0.0% C: 0.0%
market

Global Gene Therapy Market Research Report 2022-2031 Featuring Major Players - Novartis AG; Bluebird bio, Inc.; Spark Therapeutics, Inc; Audentes Therapeutics; Voyager Therapeutics
Published: 2022-06-20 (Crawled : 12:00) - prnewswire.com
SNY | News | $52.62 -1.5% -0.41% |

| Email alert Add to watchlist
SNYNF | News | $104.5 |

| Email alert Add to watchlist
QURE S | $18.69 -2.2% -2.67% |

| Email alert Add to watchlist
CLLS | $3.23 3.53% -0.32% |

| Email alert Add to watchlist
SRPT | $76.29 1.42% 0.0% |

| Email alert Add to watchlist
NVSEF | News | $84.01 |

| Email alert Add to watchlist
AGTC | $0.735 19.13% 20.42% |

| Email alert Add to watchlist
BLUE A | $4.275 -2.84% -2.27% |

| Email alert Add to watchlist
NVS | News | $85.28 0.53% 0.02% |

| Email alert Add to watchlist
research report novartis therapeutics therapy market

Global Tacrolimus Market to Surpass US$ 9,380.2 Million by 2030 - Coherent Market Insights
Published: 2022-06-17 (Crawled : 19:00) - prnewswire.com
NVS | News | $85.28 0.53% 0.02% |

| Email alert Add to watchlist
NVSEF | News | $84.01 |

| Email alert Add to watchlist
ALPMF | News | $15.83 |

| Email alert Add to watchlist
MYL | $15.86 0% |

| Email alert Add to watchlist
TFFP | $6.0 5.45% -0.18% |

| Email alert Add to watchlist
ALPMY | News | $16.205 |

Manufacturing

| Email alert Add to watchlist
tacrolimus market

Biologic Therapy Market Information: By Product and Geography - Global Forecast till 2025
Published: 2022-06-17 (Crawled : 14:00) - prnewswire.com
AZNCF | News | $129.21 |

| 7.16% | O: 1.89% H: 0.0% C: -0.64%
NVS | News | $85.28 0.53% 0.02% |

| 4.73% | O: 0.07% H: 0.0% C: 0.0%
GSK | News | $43.7 0.02% 0.05% |

| 5.33% | O: -0.24% H: 0.0% C: 0.0%
NVSEF | News | $84.01 |

| 3.87% | O: 0.74% H: 0.52% C: -3.23%
GLAXF | News | $21.1 |

| 6.81% | O: 0.01% H: 0.17% C: 0.17%
ABBV | News | $153.14 0.53% 0.04% |

| 12.24% | O: 1.05% H: 0.0% C: 0.0%
SNYNF | News | $104.5 |

| 12.02% | O: -1.76% H: 5.75% C: 5.5%
JNJ | News | $182.12 -0.09% 0.1% |

| 8.21% | O: 1.35% H: 0.0% C: 0.0%
SNY | News | $52.62 -1.5% -0.41% |

| 8.29% | O: 1.39% H: 0.0% C: 0.0%
AZN | News | $66.465 -0.65% -0.42% |

| 9.3% | O: 0.59% H: 0.0% C: 0.0%
therapy market

Global Conjugated Monoclonal Antibodies (mAbs) Market Report 2022: A $12.09 Billion Market by 2026 - Forecast to 2031
Published: 2022-06-17 (Crawled : 13:20) - prnewswire.com
ABBV | News | $153.14 0.53% 0.04% |

| 12.24% | O: 1.05% H: 0.0% C: 0.0%
NVS | News | $85.28 0.53% 0.02% |

| 4.73% | O: 0.07% H: 0.0% C: 0.0%
NVSEF | News | $84.01 |

| 3.87% | O: 0.74% H: 0.52% C: -3.23%
report market

← Previous
1
2
3
4
5
6
7
8
9
…
24
25
Next →

Your saved searches

Save your searches and get alerts when important news are released.

Mentioned Today

ABBV | News | $153.14 0.53% 0.04% |

APPN | News 4 | $54.46 -1.05% 0.38% |

APPS | News | $17.62 1.62% 5.48% |

APYX | News | $6.04 1.51% 0.0% |

BNPQF | News | $50.78 |

BNPQY | News | $25.46 |

Finance and Insurance

BNPZY | News | $ 0% |

Finance and Insurance

CNXC | News | $147.67 1.63% -0.04% |

Information

CNXCV | News | $2.27 0% |

Commercial Services

DMYD | News | $16.21 0% |

DMYT | News | $22.76 0% |

DRE | News | $56.17 -2.23% 0.0% |

EPZM | News | $1.47 54.09% 7.97% |

ET | News | $10.14 0.4% 0.59% |

Industrial Services

FBNC | News | $35.7 2.32% 0.0% |

FBP | News | $13.52 0.67% 0.0% |

Health Care and Social Assistan...

FTRP | News | $0.81 1.25% 0.0% |

GRRB | News | $30.6 |

Finance and Insurance

HR | News | $27.23 1.38% 0.0% |

HTA | News | $27.7 -0.22% 0.0% |

Professional, Scientific, and T...

IE | News new | $ 0% |

n/a

IONQ | News | $4.83 -5.48% 2.07% |

LLY | News 4 | $327.27 0.51% 0.04% |

LMPX | News | $4.62 0.43% 0.0% |

NFLX | News | $189.14 -0.9% 0.52% |

Consumer Services

OBCI | News | $12.86 0.0% |

Consumer Non-Durables

OMC | News | $64.75 0.23% 0.0% |

Commercial Services

ONEW | News | $35.25 3.68% 0.0% |

Retail Trade

OSCR | News | $4.55 2.94% 0.0% |

PACB | News | $5.3 -5.53% -1.78% |

PEGA | News | $51.68 -1.97% 0.0% |

PFHC | News | $19.75 6.35% -4.95% |

PLD | News | $120.21 -1.94% 0.54% |

PSORF | News | $9.55 0% |

Consumer Services

RDUS | News | $10.205 0.94% -0.4% |

SNY | News | $52.62 -1.5% -0.41% |

SNYNF | News | $104.5 |

SPRO | News | $0.931 -0.96% 3.19% |

SREV | News | $1.45 -2.76% |

TGTX | News | $4.34 -1.36% -2.05% |

TUP | News 4 | $7.16 1.42% 0.0% |

Producer Manufacturing

USAK | News | $30.85 -0.48% -0.39% |

Transportation

USWS | News | $0.995 4.08% -0.63% |

VRCA | News | $2.195 4.03% 10.43% |

WWE | News | $61.0 0.63% 0.0% |

Consumer Services

XRAY | News | $36.74 -0.05% 0.0% |

ZEN | News | $74.65 0.65% -0.07% |